StockData
Moderna, Inc. logo

Moderna, Inc.

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 5/30567% above fair value
$220.83−0.89 (-0.40%)

Close on Nov 2, 2026Market cap $88.16BP/E –Yield –

Moderna Total operating and finance lease liabilities by Quarter

Total operating and finance lease liabilities ($M) ($M)

Moderna Total operating and finance lease liabilities: $696M in Q2 2026, down 6.1% from a year earlier.

Latest, Q2 2026
696
Period ended Jun 30, 2026
Change on a year earlier
-6.1%
741 in Q2 2025
History
28 quarters
Since Q4 2018
Sources
27
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-07-31) ↗

Reported in Form 10-Q / 10-K Note 10 (Leases).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal operating and finance lease liabilities ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026696-6.1%Form 10-Q (filed 2026-07-31) ↗
Q1 2026Mar 31, 2026708-5.0%Form 10-Q (filed 2026-05-01) ↗
Q4 2025Dec 31, 2025715-4.3%Form 10-Q (filed 2026-07-31) ↗
Q3 2025Sep 30, 2025734-45.8%Form 10-Q (filed 2025-11-06) ↗
Q2 2025Jun 30, 2025741-41.6%Form 10-Q (filed 2025-08-01) ↗
Q1 2025Mar 31, 2025745-39.8%Form 10-Q (filed 2025-05-01) ↗
Q4 2024Dec 31, 2024747-39.9%Form 10-K (filed 2026-02-20) ↗
Q3 2024Sep 30, 20241,355-6.9%Form 10-Q (filed 2024-11-07) ↗
Q2 2024Jun 30, 20241,269+8.6%Form 10-Q (filed 2024-08-01) ↗
Q1 2024Mar 31, 20241,237+11.6%Form 10-Q (filed 2024-05-02) ↗
Q4 2023Dec 31, 20231,243+3.6%Form 10-K (filed 2025-02-21) ↗
Q3 2023Sep 30, 20231,455+15.4%Form 10-Q (filed 2023-11-03) ↗
Q2 2023Jun 30, 20231,168+31.7%Form 10-Q (filed 2023-08-03) ↗
Q1 2023Mar 31, 20231,108+17.0%Form 10-Q (filed 2023-05-04) ↗
Q4 2022Dec 31, 20221,200+31.0%Form 10-K (filed 2024-02-23) ↗
Q3 2022Sep 30, 20221,261+116.3%Form 10-Q (filed 2022-11-03) ↗

Breakdown

What makes up total operating and finance lease liabilities

Cite this data

StockData. (2026). Moderna Total operating and finance lease liabilities ($M), quarterly Q4 2018–Q2 2026 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/tot-lease-liab

See every metric in the Moderna KPI table. Data updated Nov 3, 2026.